1. Home
  2. SKYW vs SUPN Comparison

SKYW vs SUPN Comparison

Compare SKYW & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SkyWest Inc.

SKYW

SkyWest Inc.

HOLD

Current Price

$96.88

Market Cap

3.5B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$48.05

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKYW
SUPN
Founded
1972
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.0B
IPO Year
1994
2010

Fundamental Metrics

Financial Performance
Metric
SKYW
SUPN
Price
$96.88
$48.05
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$123.67
$61.60
AVG Volume (30 Days)
437.5K
739.7K
Earning Date
04-23-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
33.20
N/A
EPS
2.50
N/A
Revenue
$2,971,963,000.00
$392,755,000.00
Revenue This Year
$8.35
$22.70
Revenue Next Year
$3.55
$19.14
P/E Ratio
$38.76
N/A
Revenue Growth
N/A
N/A
52 Week Low
$77.89
$32.21
52 Week High
$123.94
$59.68

Technical Indicators

Market Signals
Indicator
SKYW
SUPN
Relative Strength Index (RSI) 62.88 61.64
Support Level $95.31 $47.48
Resistance Level $101.95 $52.36
Average True Range (ATR) 2.91 1.37
MACD 0.54 0.56
Stochastic Oscillator 63.30 98.94

Price Performance

Historical Comparison
SKYW
SUPN

About SKYW SkyWest Inc.

SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. SkyWest generally provides regional flights and utilizes smaller, lower-cost aircraft to carry passengers who book tickets through partner airlines. It partners with carriers to fly and operate aircraft for a fee and may use the carriers' brands and ground support to coordinate marketing and transport passengers. The company has two reportable segments: SkyWest Airlines and SWC, which generate maximum revenue, and SkyWest Leasing activities.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: